1. Home
  2. PRTC vs HSAI Comparison

PRTC vs HSAI Comparison

Compare PRTC & HSAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRTC
  • HSAI
  • Stock Information
  • Founded
  • PRTC 2015
  • HSAI 2014
  • Country
  • PRTC United States
  • HSAI China
  • Employees
  • PRTC 90
  • HSAI N/A
  • Industry
  • PRTC Biotechnology: Pharmaceutical Preparations
  • HSAI
  • Sector
  • PRTC Health Care
  • HSAI
  • Exchange
  • PRTC Nasdaq
  • HSAI Nasdaq
  • Market Cap
  • PRTC 504.9M
  • HSAI 504.8M
  • IPO Year
  • PRTC N/A
  • HSAI 2023
  • Fundamental
  • Price
  • PRTC $20.80
  • HSAI $4.65
  • Analyst Decision
  • PRTC Buy
  • HSAI
  • Analyst Count
  • PRTC 1
  • HSAI 0
  • Target Price
  • PRTC $45.00
  • HSAI N/A
  • AVG Volume (30 Days)
  • PRTC 3.4K
  • HSAI 425.5K
  • Earning Date
  • PRTC 08-28-2024
  • HSAI 11-11-2024
  • Dividend Yield
  • PRTC N/A
  • HSAI N/A
  • EPS Growth
  • PRTC N/A
  • HSAI N/A
  • EPS
  • PRTC N/A
  • HSAI N/A
  • Revenue
  • PRTC $468,000.00
  • HSAI $251,101,295.00
  • Revenue This Year
  • PRTC N/A
  • HSAI $19.66
  • Revenue Next Year
  • PRTC $139.60
  • HSAI $46.79
  • P/E Ratio
  • PRTC N/A
  • HSAI N/A
  • Revenue Growth
  • PRTC N/A
  • HSAI 13.11
  • 52 Week Low
  • PRTC $17.08
  • HSAI $3.28
  • 52 Week High
  • PRTC $34.00
  • HSAI $11.55
  • Technical
  • Relative Strength Index (RSI)
  • PRTC 55.95
  • HSAI 51.36
  • Support Level
  • PRTC $20.35
  • HSAI $4.20
  • Resistance Level
  • PRTC $20.95
  • HSAI $4.72
  • Average True Range (ATR)
  • PRTC 0.62
  • HSAI 0.23
  • MACD
  • PRTC 0.10
  • HSAI -0.03
  • Stochastic Oscillator
  • PRTC 75.51
  • HSAI 61.64

About PRTC PureTech Health plc

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

About HSAI Hesai Group each ADS represents one Class B ordinary share

Hesai Group is engaged in the development, manufacture, and sales of three dimensional light detection and ranging solutions, or LiDAR. Its LiDAR products enable a broad spectrum of applications across passenger or commercial vehicles with advanced driver assistance systems, or ADAS, autonomous vehicle fleets providing passenger and freight mobility services, or Autonomous Mobility, and other applications such as last-mile delivery robots, street sweeping robots, and logistics robots in restricted areas, or Robotics. The Group organized its operations into two segments: the LiDAR segment and the gas detection segment, out of which LiDAR segments derives maximum revenue. Geographically, the company operates into North America, Mainland China, Europe and Other regions.

Share on Social Networks: